IBDEI20R ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33832,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,33832,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,33832,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,33833,0)
 ;;=Q61.5^^154^1706^5
 ;;^UTILITY(U,$J,358.3,33833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33833,1,3,0)
 ;;=3^Medullary Sponge Kidney
 ;;^UTILITY(U,$J,358.3,33833,1,4,0)
 ;;=4^Q61.5
 ;;^UTILITY(U,$J,358.3,33833,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,33834,0)
 ;;=Q61.3^^154^1706^7
 ;;^UTILITY(U,$J,358.3,33834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33834,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,33834,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,33834,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,33835,0)
 ;;=E11.65^^154^1707^11
 ;;^UTILITY(U,$J,358.3,33835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33835,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,33835,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,33835,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,33836,0)
 ;;=E10.65^^154^1707^6
 ;;^UTILITY(U,$J,358.3,33836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33836,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,33836,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,33836,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,33837,0)
 ;;=E11.21^^154^1707^9
 ;;^UTILITY(U,$J,358.3,33837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33837,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,33837,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,33837,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,33838,0)
 ;;=E10.29^^154^1707^3
 ;;^UTILITY(U,$J,358.3,33838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33838,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,33838,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,33838,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,33839,0)
 ;;=E10.21^^154^1707^4
 ;;^UTILITY(U,$J,358.3,33839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33839,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,33839,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,33839,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,33840,0)
 ;;=E11.40^^154^1707^10
 ;;^UTILITY(U,$J,358.3,33840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33840,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,33840,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,33840,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,33841,0)
 ;;=E10.40^^154^1707^5
 ;;^UTILITY(U,$J,358.3,33841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33841,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,33841,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,33841,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,33842,0)
 ;;=E10.22^^154^1707^2
 ;;^UTILITY(U,$J,358.3,33842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33842,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,33842,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,33842,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,33843,0)
 ;;=E10.9^^154^1707^7
 ;;^UTILITY(U,$J,358.3,33843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33843,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,33843,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,33843,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,33844,0)
 ;;=E11.22^^154^1707^8
 ;;^UTILITY(U,$J,358.3,33844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33844,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,33844,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,33844,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,33845,0)
 ;;=E11.9^^154^1707^12
 ;;^UTILITY(U,$J,358.3,33845,1,0)
 ;;=^358.31IA^4^2
